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sorting receptor SorCS1 as a major
regulator of receptor trafficking and show
that SorCS1 maintains synaptic levels of
key adhesion and neurotransmitter
receptors.
Neuron
ArticleThe Sorting Receptor SorCS1 Regulates
Trafficking of Neurexin and AMPA Receptors
Jeffrey N. Savas,1,5 Luı´s F. Ribeiro,2 Keimpe D. Wierda,2 Rebecca Wright,3 Laura A. DeNardo-Wilke,3 Heather C. Rice,2
Ingrid Chamma,4 Yi-Zhi Wang,5 Roland Zemla,6 Mathieu Lavalle´e-Adam,1 Kristel M. Vennekens,2 Matthew L. O’Sullivan,3
Joseph K. Antonios,3 Elizabeth A. Hall,5 Olivier Thoumine,4 Alan D. Attie,7 John R. Yates III,1,* Anirvan Ghosh,3,8
and Joris de Wit2,*
1Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA
2VIB Center for the Biology of Disease, 3000 Leuven, Belgium; Center for Human Genetics, KU Leuven, 3000 Leuven, Belgium
3Neurobiology Section, Division of Biology, University of California, San Diego, La Jolla, CA 92093, USA
4UMR 5297, Interdisciplinary Institute for Neuroscience, University of Bordeaux and Centre National de la Recherche Scientifique,
33000 Bordeaux, France
5Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
6School of Medicine, New York University, New York, New York 10016, USA
7Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA
8Neuroscience Discovery, F. Hoffman-La Roche, 4070 Basel, Switzerland
*Correspondence: jyates@scripps.edu (J.R.Y.), joris.dewit@cme.vib-kuleuven.be (J.d.W.)
http://dx.doi.org/10.1016/j.neuron.2015.08.007SUMMARY
The formation, function, and plasticity of synapses
require dynamic changes in synaptic receptor com-
position. Here, we identify the sorting receptor
SorCS1 as a key regulator of synaptic receptor traf-
ficking. Four independent proteomic analyses iden-
tify the synaptic adhesion molecule neurexin and
the AMPAglutamate receptor (AMPAR) asmajor pro-
teins sorted by SorCS1. SorCS1 localizes to early and
recycling endosomes and regulates neurexin and
AMPAR surface trafficking. Surface proteome anal-
ysis of SorCS1-deficient neurons shows decreased
surface levels of these, and additional, receptors.
Quantitative in vivo analysis of SorCS1-knockout
synaptic proteomes identifies SorCS1 as a global
trafficking regulator and reveals decreased levels
of receptors regulating adhesion and neurotrans-
mission, including neurexins and AMPARs. Conse-
quently, glutamatergic transmission at SorCS1–defi-
cient synapses is reduced due to impaired AMPAR
surface expression. SORCS1 mutations have been
associated with autism and Alzheimer disease, sug-
gesting that perturbed receptor trafficking contrib-
utes to synaptic-composition and -function defects
underlying synaptopathies.
INTRODUCTION
Proper formation and function of synapses require the coordi-
nated assembly of large and heterogeneous protein complexes
on the pre- and postsynaptic side. The composition of the syn-
aptic proteome varies with synaptic neurotransmitter type and
developmental stage, changes upon activity-induced changes764 Neuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc.in synaptic strength, and is affected in synaptopathies (Cajigas
et al., 2010; Grant, 2012).
Receptors are core components of the synaptic proteome.
Their dynamic trafficking is a key feature underlying the function
and plasticity of synapses (Choquet and Triller, 2013). The trans-
port and synaptic insertion and removal of AMPA glutamate
receptors (AMPARs), for example, are tightly regulated in order
to control synaptic efficacy (Shepherd andHuganir, 2007). Adhe-
sion molecules are another key class of synaptic receptors
(Giagtzoglou et al., 2009). Neurexin (Nrxn) presynaptic adhesion
molecules play a central role in the formation, maturation, and
plasticity of synapses (Krueger et al., 2012). Nrxns interact with
distinct postsynaptic adhesion molecules, including neuroligins
(Nlgns) and LRRTMs (de Wit et al., 2009; Dean et al., 2003;
Graf et al., 2004; Ichtchenko et al., 1995; Ko et al., 2009; Scheif-
fele et al., 2000; Siddiqui et al., 2010). Some adhesionmolecules,
such as the LRRTMs, also interact with AMPARs (de Wit et al.,
2009; Schwenk et al., 2012). Furthermore, presynaptic Nrxn
regulates postsynaptic AMPAR trafficking via a trans-synaptic
interaction with Nlgns and LRRTMs (Aoto et al., 2013). Adhesion
molecules and neurotransmitter receptors are thus closely linked
and are key components of the synaptic machinery. However, in
contrast to AMPARs, little is known about the mechanisms regu-
lating adhesion molecule trafficking.
As core synaptic receptors, adhesion molecules and AMPARs
might be co-regulated. To test this idea, we took Nrxn as a
central synaptic component, screened for Nrxn-interacting pro-
teins with a role in trafficking, and then determined whether that
mechanism is sharedmore broadly among other synaptic recep-
tors. We identified the VPS10P sorting receptor SorCS1 as a
Nrxn-interacting protein. Vacuolar protein sorting 10 (VPS10P)-
receptor-family proteins are important regulators of intracellular
trafficking (Hermey, 2009; Willnow et al., 2008). The mammalian
VPS10P receptors Sortilin and SorLA sort cargo proteins in
Golgi-to-endosome trafficking pathways (Nielsen et al., 2007;
Nielsen et al., 2001). Less is known about the sorting function
and endogenous cargo of the three remaining mammalian
VPS10P receptors, SorCS1–SorCS3 (sortilin-related CNS ex-
pressed). SorCS genes are expressed in complementary pat-
terns in the brain (Hermey et al., 2004; Oetjen et al., 2014) and
have been associated with autism, schizophrenia, bipolar disor-
der, attention deficit hyperactivity disorder, and late-onset Alz-
heimer disease (Christoforou et al., 2011; Grupe et al., 2006;
Lionel et al., 2011; Ollila et al., 2009; Reitz et al., 2011; Sanders
et al., 2012). The prominent association of SORCS genes with
synaptopathies and the discovery of SorCS receptors in a
Nrxn-interactor screen suggest that SorCS proteins might play
a role in the trafficking of synaptic components.
Here, we identify Nrxn and AMPARs as key synaptic proteins
sorted by SorCS1. SorCS1 localizes to early and recycling endo-
somal compartments and regulates surface trafficking of Nrxn
and AMPARs. SorCS1 interactome analysis reveals close asso-
ciation with several synaptic proteins, including Nrxn, Nlgn, and
AMPARs. Quantitative surface proteome analysis reveals re-
duced surface expression of these proteins in SorCS1-deficient
neurons. In vivo quantitative analysis of SorCS1-knockout syn-
aptic proteomes shows decreased abundance of receptors,
including Nrxns and AMPARs, regulating adhesion and synaptic
transmission. Loss of SorCS1 reduces glutamatergic synaptic
transmission as a result of impaired surface expression of
AMPARs at excitatory synapses. Together, our results identify
SorCS1 as a major trafficking regulator of receptors that are
essential for synaptic function.
RESULTS
Identification of SorCS1 as a Nrxn-Binding Protein
To discover Nrxn-interacting proteins, we used a combination
of affinity chromatography with Nrxn ectodomains and mass
spectrometric (MS) analysis (Savas et al., 2014) (Figure 1A). We
purified recombinant Nrxn1b-Fc proteins lacking or containing
splice site 4 (Nrxn1b[ or +SS4]-Fc) (Figure S1A), the best-char-
acterized Nrxn splice site in terms of protein interactions
(Krueger et al., 2012), and used these to identify interacting pro-
teins in detergent-solubilized rat-brain homogenate. We identi-
fied Nlgn1–Nlgn3 as Nrxn-binding proteins with a preference
for Nrxn1b(SS4)-Fc (Figure 1B) (Boucard et al., 2005) and
identified LRRTM1 as a Nrxn1b(SS4)-Fc-specific interactor
(Ko et al., 2009; Siddiqui et al., 2010) (Table S1), validating our
approach.
Strikingly, the two most abundant Nrxn1b-interacting proteins
identified in this experiment were the VPS10P sorting receptor
proteins SorCS1 and SorCS2 (Figure 1B). The identification of
SorCS proteins as candidate Nrxn interactors was particularly
interesting, given that these have not previously been identified
as Nrxn-binding proteins and might be involved in regulating
Nrxn trafficking. SorCS1 and SorCS2 are members of the
VPS10P family, which regulates intracellular trafficking and
neuronal function (Hermey, 2009; Willnow et al., 2008), but the
endogenous cargo and trafficking functions of SorCS proteins
are not well understood. To determine whether Nrxn also inter-
acts with SorCS at synapses, we repeated our affinity chroma-
tography experiment by using synaptosome extracts and again
identified Nlgn1–Nlgn3 and SorCS1 and SorCS2 as the most
abundant Nrxn1b-interacting proteins (Figures 1C and 1D; TableS1). The other mammalian VPS10P receptors Sortilin and SorLA
were not identified in these experiments (Table S1). The interac-
tion of Nrxn1b with SorCS was lost at high detergent concentra-
tions, whereas the interaction with Nlgns was not (Figure S1B),
suggesting that the Nrxn1b-SorCS complex is less stable than
Nrxn1b-Nlgn. Finally, affinity purifications with an antibody
against the common Nrxn cytoplasmic domain independently
identified SorCS1 (Figure S1C). These experiments suggest
that SorCS1 is a novel endogenous Nrxn-binding partner.
To verify the MS results, we carried out a series of binding
assays. We expressed SorCS1cb-myc in HEK293T cells and
applied Nrxn1b( or +SS4)-Fc to assess surface binding. Both
Nrxn1b-Fc proteins bound to SorCS1 and the positive control
Nlgn1, whereas Fc alone showed no detectable binding (Fig-
ure 1E). Rather than labeling the cell surface, Nrxn1b-Fc
clustered in large intracellular puncta (Figure 1E), suggesting
internalization of Nrxn1b by SorCS1. In reciprocal experi-
ments, SorCS1-ecto-His strongly bound to cells expressing
Nrxn1b-CFP but not to cells expressing GFP (Figure S1D). Com-
plementary pulldown assays with transfected HEK cell lysates
confirmed the SorCS1-Nrxn1b interaction (Figures S1E and
S1F). Direct binding assays demonstrated that SorCS1-ecto-
His coprecipitated with Nrxn1b-Fc but not with the control pro-
teins LPHN3-Fc (O’Sullivan et al., 2012) or Fc alone (Figure 1F),
showing a direct interaction between the SorCS1 and Nrxn1b
ectodomains.
To estimate the affinity of the interaction, we measured
SorCS1-Nrxn1b cell surface binding. Scatchard analysis indi-
cated a Kd = 2.22 ± 0.87 nM after subtracting non-specific
binding to control cells (Figure 1G), demonstrating an apparent
high-affinity binding of SorCS1 to cell surface Nrxn1b. To identify
the domain in SorCS1 required for Nrxn1b binding, we analyzed
Nrxn1b-Fc binding to full-length (FL) SorCS1cb and to SorCS1
mutants lacking the pro-peptide domain (DPRO), the ligand-
binding VPS10P domain (DVPS), the polycystic kidney disease
domain (DPKD), or the leucine-rich domain (DLRD) (Figure 1H).
Surface expression was confirmed for all SorCS1 mutants (Fig-
ure S1G). Deletion of the VPS10P domain abolished SorCS1
binding to Nrxn1b in both pulldown (Figure 1I) and surface-bind-
ing assays (Figure 1J). Together, these results show that the
SorCS1-Nrxn1b interaction is direct, has high affinity, and re-
quires the VPS10P domain.
SorCS1 Localizes to Endosomal Compartments and
Excitatory Synapses
The identification of SorCS1 as a Nrxn interactor suggests that
SorCS1 may localize to synapses. Punctate SorCS1 immunore-
activity has been observed in neuronal cell bodies and dendrites
(Hermey et al., 2001), but the nature of these SorCS1-positive
compartments is unclear. To gain insight into the subcellular
localization of SorCS1, we first labeled HeLa cells expressing
HA-SorCS1cb with a panel of antibodies for intracellular com-
partments. SorCS1 displayed a punctate distribution throughout
the cytoplasm, where it partially colocalized with the early endo-
some marker EEA1 (Figure 2A). Robust colocalization was
observed with Alexa 568-transferrin (Tf; 30 min uptake) (Fig-
ure 2B) and with the transferrin receptor (TfR; Figure S2A).
SorCS1 also colocalized with the recycling endosome markerNeuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc. 765
Figure 1. Identification of SorCS1 as a Nrxn-Binding Protein
(A) Proteomic workflow for the identification of Nrxn1b-interacting proteins
(B) Frequency of detection of all peptides (total spectra count) for proteins identified in both Nrxn1b(+SS4)-Fc and Nrxn1b(SS4)-Fc affinity purifications after
background (Fc alone) subtraction with whole-brain prey extracts.
(C) Nrxn1b-Fc affinity purification as in (B) with synaptosome prey extracts.
(D) SorCS1 protein domain organization with mapped peptide MS identifications (red) from synaptosome prey experiment with Nrxn1b(+SS4) bait. Sig, signal
peptide; Pro, pro-peptide; VPS10P, vacuolar protein sorting 10 protein; PKD, polycystic kidney disease domain; LRD, leucine-rich domain; ICD, intracellular
domain.
(E) Surface-binding experiments with Nrxn1b-Fc or control Fc on HEK293T cells expressing SorCS1cb-myc or FLAG-Nlgn1.
(F) Direct binding assay with Fc proteins and SorCS1-ecto-His.
(G) Estimation of SorCS1/Nrxn1b binding affinity. Representative experiment demonstrating concentration-dependent SorCS1-ecto-His binding to FLAG-
Nrxn1b(SS4)-expressing HEK cells (n = 3 independent experiments).
(legend continued on next page)
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Rab11 and the trans Golgi network marker TGN-46, but dis-
played little overlap with the late endosomal marker CD63 or
the lysosomal marker LAMP1 (Figures 2C and S2B–D). These
observations suggest that SorCS1 localizes to endosomal recy-
cling compartments in HeLa cells.
To determine the subcellular localization of SorCS1 in neu-
rons, we tested a wide panel of commercially available and
custom-made SorCS1 antibodies but found that none were suit-
able for the immunocytochemical detection of SorCS1 (data not
shown). We therefore expressed epitope-tagged SorCS1cb in
cultured neurons. SorCS1 displayed a punctate distribution in
cell body and dendrites. Quantification of the intensity of SorCS1
fluorescence in axons and dendrites showed a distribution
comparable to that of the somatodendritic marker TfR-GFP (Fa-
rı´as et al., 2012), indicating that SorCS1 predominantly localizes
to the somatodendritic compartment (Figures 2D–2G). In den-
drites, SorCS1 puncta colocalized with EEA1, Alexa 568-Tf
(60 min uptake) (Figures 2H, 2I, and 2K), and TfR (Figures 2K
and S2E), but showed less overlap with TGN-46, CD-63, or
LAMP1 (Figures 2K and S2F–S2H). Co-expression of SorCS1
and Rab-GFP constructs for labeling different endosomal com-
partments revealed the highest overlap of SorCS1 with the early
and recycling endosome markers Rab4, Rab5, and Rab11, but
not with the late endosome marker Rab7 (Figurse 2L and
S2JN–S2M). These results indicate that SorCS1 localizes to en-
dosomal compartments in dendrites and spines.
We next compared the localization of SorCS1 to synaptic
markers. SorCS2 and SorCS3 are postsynaptic density proteins
(Baye´s et al., 2012; Breiderhoff et al., 2013), suggesting that
SorCS1 might also be synaptic. SorCS1 colocalized with the
excitatory postsynaptic marker PSD95 in dendritic spines (Fig-
ures 2J and 2K) and was juxtaposed to the presynaptic marker
VGluT1 (Figures 2K and S2I). Subcellular fractionation (Fig-
ure S2N) with a verified SorCS1 antibody (Figures S2O–S2Q)
showed SorCS1 immunoreactivity in purified postsynaptic den-
sity fractions, which contained PSD95. Little SorCS1 was de-
tected in the presynaptic fraction containing synaptophysin.
Thus, SorCS1 predominantly localizes to early and recycling
endosomes, consistent with a role in sorting cargo proteins. In
addition, SorCS1 can be detected at the postsynaptic density
of glutamatergic synapses.
SorCS1 Regulates the Cell Surface Distribution of Nrxn
The endosomal localization of SorCS1 is consistent with a role in
the intracellular sorting of cargo proteins and the regulation of
receptor surface distribution. If SorCS1 regulates the cell surface
distribution of Nrxn, SorCS1 and Nrxn would be expected to co-
localize. SorCS1 localizes to the somatodendritic compartment
(Figure 2D-G), whereas Nrxn predominantly functions presynap-
tically. However, several studies have reported additional den-
dritic localization of Nrxn (Berninghausen et al., 2007; Fairless
et al., 2008; Taniguchi et al., 2007). We first assessed SorCS1
and Nrxn localization and found that both proteins colocalized(H) SorCS1 deletion mutants.
(I) Pulldown experiment with Nrxn1b(+SS4)-Fc on HEK cell lysates transfected w
(J) Binding of Nrxn1b(+SS4)-Fc to HEK cells expressing SorCS1 deletion constr
Figure S1.in endosomes in HeLa cells and in dendrites (Figures S3A–
S3C), corroborating previous results demonstrating localization
of Nrxn1b in dendritic endosomes (Taniguchi et al., 2007). Sub-
cellular fractionation further indicated a pool of endogenous
Nrxn in the postsynaptic fraction (Figure S2N), confirming previ-
ous observations (Berninghausen et al., 2007). Their endosomal
colocalization suggests that SorCS1 and Nrxn might preferen-
tially interact in cis. To test whether SorCS1 and Nrxn interact
in cis or in trans, we performed antibody-mediated aggregation
experiments and found that clustering of SorCS1 resulted in
VPS10P domain-dependent coaggregation of Nrxn1b or vice
versa (Figure S3D). Coculture assays for testing whether SorCS1
might also interact with Nrxn in trans did not support a trans inter-
action (Figures S3E–S3G), indicating a preferential cis interaction
of SorCS1 and Nrxn.
To determine whether SorCS1 regulates Nrxn surface levels,
we first overexpressed SorCS1cb-myc (FL or DVPS) in hippo-
campal neurons. These neurons express SorCS2 and SorCS3
but express SorCS1 at very low levels or not at all (Hermey
et al., 2004; Oetjen et al., 2014). We tested multiple Nrxn anti-
bodies but none of these proved suitable for the detection of
endogenous cell surface Nrxn (data not shown). We therefore
expressed Nrxn1b(SS4) tagged with an extracellular epitope
(SEP-Nrxn1b) to analyze Nrxn surface levels. Overexpression
of SorCS1 FL, but not of SorCS1 DVPS, significantly decreased
the ratio of surface/total SEP-Nrxn1b in dendrites in comparison
to that in control cells (Figures 3A and 3B). We next tested the
effect of loss of SorCS1 on dendritic Nrxn surface levels. We
cultured cortical neurons, which strongly express SorCS1 (Her-
mey et al., 2004; Oetjen et al., 2014), from SorCS1flox/flox mice
(Lane et al., 2010) and expressed Cre recombinase in these cells
to reduce SorCS1 levels. Compared to that in control cells, the
surface/total SEP-Nrxn1b ratio was significantly increased in
SorCS1 KO dendrites (Figures 3C and 3D). This increase in sur-
face/total SEP-Nrxn1b ratio was due to both an increase in
SEP-Nrxn1b dendritic surface intensity (Figure 3E) and a small
decrease in SEP-Nrxn1b total intensity in SorCS1 KO dendrites
(Figure 3F). These results indicate that overexpression of SorCS1
decreases, whereas loss of SorCS1 increases, dendritic Nrxn
surface levels.
Although Nrxn is present on the dendritic surface, the majority
of Nrxn is expressed on the axonal surface (Fairless et al.,
2008), which is functionally the most important site for Nrxns.
To determine whether loss of SorCS1 might also affect axonal
Nrxn surface levels, we analyzed the SEP-Nrxn1b surface/total
ratio in SorCS1-deficient axons. We observed strong SEP-
Nrxn1b surface expression in control axons (Figure 3G) and
found that the surface/total SEP-Nrxn1b ratio was significantly
decreased in SorCS1 KO axons (Figures 3G and 3H). This
decrease underestimates the extent of downregulation of
axonal Nrxn surface expression in SorCS1 KO neurons because
we observed both a robust decrease in axonal SEP-Nrxn1b
surface intensity (Figure 3I) and a decrease in total SEP-Nrxn1bith SorCS1 deletion constructs.
ucts or myc-LRRTM2 as a control. Scale bars in (E) and (J), 10 mm. See also
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Figure 2. SorCS1 localizes to endosomal compartments and excitatory synapses.
(A–C) SorCS1 localization in HeLa cells.
(legend continued on next page)
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intensity (Figure 3J). Together, these results show that SorCS1
controls Nrxn surface distribution in neurons in a compartment-
specific manner: SorCS1 overexpression removes Nrxn from
the dendritic surface, whereas SorCS1 KO results in Nrxn accu-
mulation on the dendritic surface and a loss of Nrxn from the
axonal surface.
Because the total Nrxn intensity is decreased in SorCS1 KO
neurons (Figures 3F and 3J), we asked whether loss of SorCS1
affects total Nrxn levels. We analyzed whole cell lysates of
DIV14 (days in vitro) SorCS1flox/flox cortical neurons infected
with a lentiviral vector encoding Cre recombinase (LV-Cre) by
western blot and found a significant decrease in total Nrxn1b
levels compared to those in control neurons (Figures 3K and
3L). To test whether Nrxn is degraded in SorCS1 KO neurons,
we quantified the overlap of SEP-Nrxn1b with the lysosomal
marker LAMP1 and found a significantly increased overlap
compared to that in control cells (Figures S3H and S3I), suggest-
ing that Nrxn undergoes lysosomal degradation in the absence
of SorCS1. Taken together, these results demonstrate that in
the absence of SorCS1-mediated sorting, Nrxn is mis-sorted
to the dendritic surface, lost from the axonal surface, and ulti-
mately degraded.
SorCS1 Interactome Analysis Identifies Nrxns and Other
Synaptic Receptors
As a sorting receptor, SorCS1 might regulate the surface traf-
ficking of additional receptors besides Nrxn. To determine
whether SorCS1 interacts with additional receptors, we charac-
terized the molecular composition of the SorCS1 complex
in the brain. We first performed affinity chromatography by
using recombinant SorCS1-ecto-His as bait and detergent-
solubilized synaptosome extract as prey, followed by MS
analysis (‘‘SorCS1-ecto MS’’; Figure 4A). Coomassie staining
showed an enrichment of proteins, which was absent when the
SorCS1-ecto-His bait or the anti-His antibody were omitted, in
the SorCS1-ecto-His pulldown lanes (Figure 4A). As expected,
SorCS1-ecto MS detected Nrxn1 and Nrxn2 (Figures 4C and
S4A; Table S2).
We identified multiple receptors, in addition to Nrxns, in the
SorCS1 ectodomain interactome, several of which were synap-
tic. These included the synaptic adhesion molecules Nlgn1 and(A) HA-SorCS1cb (green) colocalizes with early endosome marker EEA1 (red).
(B) HA-SorCS1cb colocalizes with internalized Alexa 568-transferrin (Tf) (red).
(C) HA-SorCS1cb does not colocalize with late endosome marker CD63 (red).
(D–L) SorCS1 localization in neurons.
(D–G) DIV14 hippocampal neurons expressing GFP, TfR-GFP, or SorCS1cb-myc
initial segment marker; in blue, not shown) to determine SorCS1 somatodendritic
dendritic distribution of GFP (D), TfR-GFP (E), and SorCS1cb-myc (F).
(G) Quantification of dendritic versus axonal distribution (D:A – polarity index)
dendrites; D:A < 1, preferential axonal distribution; and D:A > 1, preferential dendr
experiments.
(H) HA-SorCS1cb (green) coexpressed with GFP (blue) colocalizes with EEA1 (re
(I) HA-SorCS1cb colocalizes with Alexa 568-Tf (red) in dendrites and spines (arro
(J) SorCS1cb-myc shows a partial overlap with postsynaptic excitatory marker P
(K and L) Quantification of the colocalization of HA-SorCS1cb with different mar
mean ± SEM. Scale bars in (A–C), 1 mm; scale bars in (D–F), 10 mm; scale bars inNlgn3 (Figure 4C, 4D, and S4A; Table S2), and the AMPAR sub-
unit Gria2 (GluA2) (Figure 4C and S4A; Table S2). Various other
receptors were also present, including members of the Plexin
semaphorin receptor family, the previously identified SorCS1 in-
teractor amyloid precursor protein (APP) (Lane et al., 2010), and
Ntrk2 (TrkB), the receptor for the neurotrophin BDNF (Table S2).
The results from the SorCS1 ectodomain interactome analysis
suggest that SorCS1 interacts with multiple receptors and may
regulate key synaptic functions.
In a complementary approach, to also identify proteins inter-
acting with the SorCS1 cytoplasmic tail, we affinity purified
SorCS1 complexes from rat-brain extract by using two indepen-
dent antibodies against SorCS1 (Figures S2O–S2Q) and a rabbit
IgG control antibody, followed by LC-MS/MS analysis (‘‘SorCS1
AP-MS’’; Figure 4B). SorCS2 and SorCS3 were not detected
in these samples (Table S3), supporting specificity of the
antibodies used. Proteomic analysis of affinity-purified SorCS1
complexes revealed a prominent presence of adaptor protein
(AP)-2-complex subunits (Figure S4B; Table S3), confirming pre-
vious findings (Nielsen et al., 2008). In addition to AP-2, which is
important for clathrin-mediated endocytosis, the plasma-mem-
brane clathrin-coat components Eps15 and epsins were also
present in the SorCS1 complex (Figure S4B; Table S3), indi-
cating that the SorCS1 cytoplasmic domain couples to the endo-
cytic machinery. Confirming the SorCS1-ecto MS results, we
again identified peptides for the synaptic adhesion molecules
Nrxn2 and Nlgn3 and the AMPAR subunits Gria2 (GluA2) and
Gria3 (GluA3) in the affinity-purified SorCS1 complex (Figures
4C, 4E, and S4B; Table S3). Together, these results show that
SorCS1 complexes captured from brain-membrane extracts
contain synaptic adhesion molecules and AMPA glutamate
receptors.
Multiple Neuronal Receptors Depend on SorCS1 for
Surface Trafficking
The presence of additional receptors besides Nrxn in the SorCS1
interactome suggests that SorCS1 may more broadly regulate
receptor surface trafficking. To determine whether multiple re-
ceptors depend on SorCS1 for their surface trafficking, we per-
formed a global, quantitative analysis of the surface proteome
in control and SorCS1-deficient neurons by using stable isotopewere immunostained for MAP2 (dendritic marker; in red) and ankyrin G (axon
versus axonal distribution. Shown are representative images with axonal and
of GFP, TfR-GFP and SorCS1cb. D:A = 1, uniform distribution in axons and
itic distribution. Number in bars indicates n for each condition in 3 independent
d) in dendrites and spines of hippocampal neurons (arrows).
ws).
SD95 (red) in dendritic spines (arrows).
kers in neurons in 3 independent experiments (n = 15 cells). Bar graphs show
(H–J), 2 mm. See also Figure S2.
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Figure 3. SorCS1 Regulates Nrxn Surface Distribution in Neurons
(A and B) SorCS1 gain-of-function experiments.
(A) Rat hippocampal neurons were co-transfected with SEP-Nrxn1b(SS4) and an empty vector or SorCS1cb-myc constructs and immunostained for GFP under
non-permeabilizing conditions to label surface SEP-Nrxn1b. Overexpression of SorCS1cb-myc full-length (FL), but not SorCS1b-mycDVPS, decreases dendritic
Nrxn1b surface levels.
(B) Quantification of the dendritic Nrxn1b surface/total intensity ratio. **p < 0.01 by t test with non-parametric Mann-Whitney rank-sum test.
(C–L) SorCS1 loss-of-function experiments.
(C) SorCS1flox/flox cortical neurons were co-electroporated with SEP-Nrxn1b(SS4) and an empty vector (control) or Cre-myc (Cre). Loss of SorCS1 increases
dendritic Nrxn1b surface levels.
(D) Quantification of dendritic Nrxn1b surface/total intensity ratio.
(E) Loss of SorCS1 increases dendritic Nrxn1b surface intensity.
(F) Dendritic Nrxn1b total intensity is reduced in SorCS1 KO neurons.
(legend continued on next page)
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Figure 4. SorCS1 Interactome Analysis Identifies Synaptic Adhesion Molecules and AMPA Glutamate Receptors
(A) Schematic representation recombinant His-tagged SorCS1-ectodomain (SorCS1-ecto-His) interaction screen. Representative Coomassie-stained gel of
proteins bound to bead-coupled SorCS1-ecto-His incubated with synaptosome extracts, with indicated negative control purifications. Asterisks indicate non-
specific background bands.
(B) SorCS1 complex affinity-purification scheme. SorCS1 complexes were immunoprecipitated from whole postnatal rat-brain extracts with two independent
SorCS1 antibodies and rabbit IgG controls. Western blot analysis of immunoprecipitated SorCS1 complexes with SorCS1 andGluN2B antibodies shows specific
SorCS1 enrichment.
(C) MS summary table for SorCS1-ecto-His and SorCS1 affinity purifications (SorCS1-ecto-His MS and SorCS1 AP-MS, respectively). Indicated is the number of
peptides and spectral counts (in parentheses) for each protein in both purification schemes with negative controls (see Tables S2 and S3 and Supplemental
Experimental Procedures).
(D) Western blot validation for the recovery of the bait SorCS1-ecto-His and prey Nlgn3 proteins but not GluN2B.
(E) Western blot validation for the recovery of Nlgn3 in immunoprecipitated SorCS1 complexes. See also Figure S4.labeling by amino acids in culture (SILAC). Cortical and hippo-
campal neurons were cultured from SorCS1flox/flox mice and
divided into two sets. One set of control neurons was cultured
in media containing stable heavy arginine and lysine isotopes
and was mock infected (‘‘heavy’’); the other set of neurons was
cultured in normal media and infected with LV-Cre (‘‘light’’) to
reduce SorCS1 levels (SorCS1 cKO). The two sets of neurons
were then surface biotinylated, lysed, mixed 1:1, and precipi-
tated with neutravidin beads, followed by MS analysis (‘‘SorCS1
cKO surface SILAC analysis’’; Figures 5A and S5A). We per-
formed two independent experiments and quantified between(G) Loss of SorCS1 decreases axonal Nrxn1b surface levels.
(H) Quantification of axonal Nrxn1b surface/total intensity ratio.
(I) Loss of SorCS1 reduces axonal Nrxn1b surface intensity.
(J) Axonal Nrxn1b total intensity is reduced in SorCS1KO neurons. *p < 0.05, **p <
show mean ± SEM; number in bars indicates n for each condition. Scale bars in
(K) Extracts from DIV14 SorCS1flox/flox cortical neurons infected with LV-Cre at D
(L) Quantification of (K). **p < 0.01 by Student’s t test. Bar graph shows mean ±1,999 and 2,151 proteins from 7,869 and 10,146 peptides,
respectively (Figures 5B and S5B–S5D). The corrected ratios
(light/heavy) of the quantified peptides show a normal distribu-
tion with a tail representing peptides with a reduced ratio in
SorCS1 cKO cultures (Figure 5B), indicating a specific downre-
gulation of surface proteins in SorCS1 KO cultures.
Manual inspection of the raw MS1 mass-to-charge ratio (m/z)
spectra indicated reduced surface levels of Nrxn1 and Nlgn3,
whereas the surface abundance of the cell adhesion molecule
Ncam1 was not affected (Figure 5C). We then graphed the
light/heavy (SorCS1 cKO/control) ratios for each experiment on0.01, and ***p < 0.001 byMann-Whitney test. Bar graphs in (B), (D–F), and (H–J)
(A), (C,) and (G), 5 mm.
IV2 show reduced Nrxn1b levels in comparison to those in control cells.
STD; number in bars indicates n for each condition. See also Figure S3.
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Figure 5. Quantitative Surface ProteomeAnalysis Reveals Reduced Surface Levels of Nrxn, Nlgn, and AMPARs in SorCS1-Deficient Neurons
(A) Experimental scheme SorCS1 cKO surface SILAC analysis. Mock-infected SorCS1flox/flox neurons were grown in SILAC media (heavy, blue) and biotinylated
surface proteins were isolated and quantified compared to LV-Cre-infected SorCS1flox/flox neurons (SorCS1 cKO; light, red) using MS (see Supplemental
Experimental Procedures).
(B) Corrected peptide ratio distributions for 2 independent biological replicates (experiment 1 and 2) show normal distributions with tails skewed toward peptides
with a reduced SILAC ratio in the SorCS1 cKO condition (dotted blue box).
(C)RawMS1scans forNrxn1andNlgn3 show reduced intensity forSorCS1 cKOcondition (red)whileNcam1 is unchanged.Starredpeakswere identifiedbyMS/MS.
(D) Cross-hair scatter plot from two independent experiments shows that Nrxn1 and Nrxn2, Nlgn3, andGria1 andGria2 are among themost strongly downregulated
proteins in SorCS1-deficient neurons. Proteins measured as downregulated in one experiment but unquantified in the other are shown on that axis as 0. Outlined
proteins were determined as significantly downregulated (see Supplemental Experimental Procedures). Student’s t test p < 0.05; n = 1,297 proteins. See also
Figure S5.a logarithmic scale, with the lowest ratios indicating the most
strongly decreased proteins in SorCS1-deficient neurons. This
global surface proteome analysis also identified Nrxn1 and
Nrxn2 as among the proteins with the strongest decrease in sur-
face expression after loss of SorCS1 (Figure 5D; Table S4). The
surface levels of Nlgn3 and the AMPAR subunit Gria2 (GluA2),
proteins that were identified in the SorCS1 interactome analysis
(Figure 4; Tables S2 and S3), were also decreased (Figure 5D).772 Neuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc.Additional receptors, such as APP and Plexin, from the SorCS1
interactome analysis showed reduced surface expression in
SorCS1 KO neurons (Table S4). Thus, multiple receptors,
including the Nrxn and Nlgn synaptic adhesion molecules and
AMPARs, depend on SorCS1 for normal surface expression.
These results identify SorCS1 as a global regulator of receptor
surface trafficking and indicate that loss of SorCS1 alters surface
proteome composition.
Figure 6. In Vivo Loss of SorCS1 Decreases Synaptic Abundance of Adhesion and Glutamate Receptors
(A) Quantitative in vivo proteomic scheme to identify synaptic proteins regulated by SorCS1. NEX-Cre:SorCS1flox/flox (n = 6) or SorCS1flox/flox (n = 5) brain region
homogenates were mixed 1:1 with 15N internal standard. Synaptosomes were prepared simultaneously and analyzed by MS (see Experimental Procedures).
(B) MS1 reconstructed chromatograms of representative peptides. Elution profile MS1 traces are shown for a representative peptide from Nrxn and Ncam1.
Internal standard 15N signal in gray, NEX-Cre:SorCS1flox/flox 14N signal in blue.
(C) Proteomic summary volcano plot, x axis = log2 SorCS1
/ / SorCS1+/+, y axis = -log10 t test p value. N = 5,882 total proteins represented: 299 (5.1%) regulated
proteins (p value% 0.05 andR 20%altered expression; blue and black open circles) and 104most-confident proteins (Benjamini-Hochberg corrected p value%
0.05 andR 20% altered expression and% 0.05; blue and black filled circles). p values = 0 were graphed as 0.00001. Nrxn3 and Gria3 were below the limit of
detection in SorCS1/ and were considered singletons (dotted oval).
(D) Panther GO biological process analysis of significantly downregulated proteins graphed in rank order by decreasing p value (154 of 191 downregulated
proteins mapped, p value < 0.05). Dotted red line indicates significance cut-off (p < 0.05).
(E)Western blot validation of SorCS1 andNrxnb levels relative to b-tubulin in synaptosome extracts used in quantitativeMS screen. **p < 0.005 by Student’s t test.
Bar graph shows mean ± STD; number in bars indicates n for each condition.
(F) Venn diagram. Four independent proteomics approaches significantly identify Nrxns and AMPARs as key proteins regulated by SorCS1 (See Supplemental
Experimental Procedures for details). See also Figure S6.In Vivo Loss of SorCS1 Decreases Synaptic Abundance
of Adhesion and Glutamate Receptors
Many of the receptors depending on SorCS1 for their surface
expression are synaptic proteins. To determine whether SorCS1
regulates receptor abundance at synapses in vivo, we performed
a quantitative analysis of synaptic proteomes fromSorCS1flox/flox
mice crossed with NEX-Cre transgenic mice to specifically
decrease SorCS1 expression in principal cortical and hippocam-
pal neurons. Cortex and hippocampus were dissected from
mature NEX-Cre:SorCS1flox/flox mice and SorCS1flox/flox control
mice, homogenized, and mixed 1:1 with an internal standard
consisting of cortex and hippocampus dissected from non-
transgenic mice that were metabolically labeled in vivo with the
stable isotope 15N (Figure 6A; Supplemental Experimental Pro-
cedures). We then performed LC-MS/MS analysis of each 14N
biological replicate with the common 15N internal standardsimultaneously to obtain relative 14N/15N peptide ratios (SorCS1
cKO 15N in vivo synapse quantitation; Figures 6A, S6A, and S6B).
We quantified a total of 5,882 proteins and found that 95% of the
synaptic proteome was not significantly affected by loss of
SorCS1. We identified 299 significantly regulated proteins
(5.1% of total proteins; t test p value% 0.05 andR 20% change
in expression), of which 191 were downregulated and 108 were
upregulated (Table S5).
Manual inspection of the raw MS1 m/z spectra indicated
downregulated levels of Nrxn1 in NEX-Cre:SorCS1flox/flox syn-
aptosomes in comparison to those in 15N controls, whereas
the abundance of Ncam1 was not altered (Figures 6B and
S6A). Overall, Nrxn1 was among the most significantly down-
regulated proteins in SorCS1-deficient synaptosomes (1.5-fold
downregulation; Figures 6C, S6C, and S6D; Table S5). To verify
the quantitative MS results, we analyzed Nrxn protein levelsNeuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc. 773
(legend on next page)
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in SorCS1flox/flox and NEX-Cre:SorCS1flox/flox synaptosomes by
western blot and found that loss of SorCS1 significantly
decreased Nrxn levels (Figures 6E and S6E).
In addition to Nrxn, several other synaptic adhesion mole-
cules were detected among the significantly downregulated
proteins in NEX-Cre:SorCS1flox/flox synaptosomes, including
Contactin-4 (Cntn4; 2-fold downregulation) and leucine-rich
repeat (LRR)-containing synaptic adhesion molecules such as
LRRC4B (NGL-3; 1.5-fold downregulation). Ionotropic glutamate
receptor abundance was also significantly decreased in SorCS1
KO synaptosomes. All four AMPAR subunits, Gria1–Gria4
(GluA1–GluA4), and the NMDA receptor subunits Grin2a
(GluN2A) and Grin2b (GluN2B) were downregulated (all 1.2-fold
downregulation; Figures 6C and S6D; Table S5). Taken together,
manual inspection of downregulated proteins suggests that loss
of SorCS1 decreases the abundance of adhesion proteins and
glutamate receptors.
We next performed Gene Ontology (GO) analysis to identify
over-represented biological processes and classes of proteins
in our dataset in an unbiased way. We compared the significantly
downregulated proteins to the total collection of quantified pro-
teins and found that cell-cell signaling, synaptic transmission,
cell adhesion, and cell communication were the four most signif-
icantly over-represented biological processes (Figures 6D, S6F,
and S6H). In contrast, GO analysis of upregulated proteins did
not reveal such significant enrichment of any process (Fig-
ure S6G). Grouping of significantly altered proteins by protein
class showed that receptors and ion channels together repre-
sented roughly half of all downregulated proteins (Figure S6I).
Thus, lossofSorCS1 in principal glutamatergic neuronsof thehip-
pocampus and cortex decreases the synaptic abundance of re-
ceptors regulatingcell adhesionandsynaptic transmission invivo.
Importantly, Nrxns and AMPARs were detected in four
different, unbiased proteomic approaches assessing SorCS1Figure 7. SorCS1 Is Required for Basal Glutamatergic and GABAergic
(A–C) Analysis of synaptic transmission in layer 5 somatosensory cortical neuro
slices.
(A) Example traces. Segregation of mEPSCs (green arrowheads) and mIPSCs (re
(B and C) mEPSC and mIPSC frequency, but not amplitude, are decreased in So
(D–F) Analysis of synaptic transmission in SorCS1flox/flox dissociated cortical neu
(D) Example traces.
(E and F) Reduced mEPSC and mIPSC frequency, but not amplitude, in SorCS1
porated neurons (Cre) or control neurons (+EGFP). *p < 0.05, **p < 0.01 by Kru
(G–J) Analysis of synapse density in SorCS1flox/flox cortical neurons.
(G and H) VGluT1- and PSD95-positive puncta density is not changed in DIV14 S
electroporated cells (control).
(I and J) Decreased density of Gephyrin- and VGAT-positive puncta in SorCS1 K
(J) ***p < 0.001 Mann-Whitney test.
(K–U) Analysis of AMPAR and GABAAR surface and synaptic expression in SorC
(K) SorCS1flox/flox cortical neurons electroporated with EGFP (control) or Cre (Cr
meabilizing conditions. After permeabilization, neurons were stained for GFP, PS
(L) Decreased GluA1 surface expression in SorCS1 KO neurons.
(M) Decreased synaptic surface levels of GluA1 in SorCS1 KO neurons.
(N–P) Decreased cell surface and synaptic GluA2 levels in SorCS1 KO neurons.
(Q) Surface GABAAR b2/3 staining in SorCS1
flox/flox cortical neurons.
(R–S) GABAAR b2/3 surface (R) and synaptic (S) expression are not affected in S
(T) DIV14 SorCS1flox/flox cortical neurons electroporated with EGFP (control) and
(U) Quantification of the density of synaptic surface GluN1 clusters lacking surfa
showmean ± SEM; number in bars indicates number of cells analyzed for each co
and (T), 5 mm; whole cell panels in (K), (N), and (Q), 20 mm. See also Figure S7.function (Figure 6F): SorCS1-ecto MS and AP-MS (Figure 4),
SorCS1 cKO surface SILAC analysis (Figure 5), and SorCS1
cKO 15N in vivo synapse quantitation (Figure 6). Specifically,
Gria2 (GluA2) was significantly identified with all four approaches
(joint probability of such event occurring by chance = 0.0009; see
Supplemental Experimental Procedures). In addition, three more
proteins were significantly detected using three of these
methods: these proteins were Nrxn1 (SorCS1 cKO 15N in vivo
synapse quantitation, SorCS1 cKO surface SILAC, and
SorCS1-ecto MS; joint probability = 0.0023), Nrxn2 (SorCS1
cKO surface SILAC, SorCS1-ecto MS, and SorCS1 AP-MS; joint
probability = 0.0107), and Gria3 (GluA3) (SorCS1 cKO 15N in vivo
synapse quantitation, SorCS1 cKO surface SILAC, and SorCS1
AP-MS; joint probability = 0.0015). Together, the combined re-
sults from four different approaches indicate that Nrxns and AM-
PARs represent key proteins depending on SorCS1 for their sur-
face and synaptic abundance.
SorCS1 Is Required for Basal Glutamatergic and
GABAergic Synaptic Transmission
In the final series of experiments, we asked how an altered
abundance of synaptic receptors in the absence of SorCS1
affects synaptic transmission. We recorded spontaneous minia-
ture excitatory and inhibitory postsynaptic currents (mEPSCs
and mIPSCs, respectively) from somatosensory layer 5 pyra-
midal neurons in P18-21 acute cortical slices from control
SorCS1flox/flox andEmx1-Cre:SorCS1flox/floxmice to assess basal
synaptic transmission. The frequency of mEPSCs and mIPSCs
was strongly decreased in Emx1-Cre:SorCS1flox/flox cortical neu-
rons in comparison to that in controls, whereas amplitude and
decay time were not affected (Figures 7A–7C and S7A–S7C).
We next cultured SorCS1flox/flox cortical neurons and electro-
porated them with Cre or GFP control plasmids. We recorded
mEPSCs and mIPSCs from DIV12–DIV16 neurons andSynaptic Transmission
ns in SorCS1flox/flox (control) and Emx1-Cre:SorCS1flox/flox (SorCS1 KO) acute
d arrowheads) was based on difference in decay time kinetics.
rCS1 KO layer 5 neurons. ***p < 0.001 by Mann-Whitney test.
rons electroporated with EGFP (control) or Cre (SorCS1 KO).
flox/flox neurons expressing Cre (+Cre) compared to neighboring non-electro-
skal-Wallis test followed by Dunn’s post hoc test.
orCS1flox/flox cortical neurons electroporated with Cre in comparison to EGFP-
O neurons.
S1flox/flox cortical neurons.
e) plasmids were immunostained on DIV14 for surface GluA1 under non-per-
D95, and VGluT1.
orCS1 KO neurons. *p < 0.05, **p < 0.01 and ***p < 0.001 Mann-Whitney test.
Cre (Cre) surface-labeled for GluN1 and GluA1.
ce GluA1 normalized to controls. *p < 0.05 by Mann-Whitney test. Bar graphs
ndition in three–four independent experiments. Scale bars in (G), (I), (K), (N), (Q),
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found a similar decrease in the frequency of these events in
SorCS1flox/flox neurons expressing Cre (+ Cre) in comparison to
that in control SorCS1flox/flox neurons (+ EGFP) (Figures 7D and
7E). Amplitude, decay time, and membrane potential were not
affected by loss of SorCS1 (Figures 7F and S7D–S7G). To test
whether the effects of loss of SorCS1 on spontaneous synaptic
transmission are cell-autonomous, we recorded mPSCs from
neighboring non-electroporated SorCS1flox/flox neurons (Cre)
in Cre-electroporated cultures. We found no change in the fre-
quency, amplitude, or decay kinetics of mEPSCs and mIPSCs
in Cre SorCS1flox/flox neurons (Figures 7E and 7F and S7D–
S7G), indicating that the effects of loss of SorCS1 on mPSC fre-
quency are cell-autonomous. Together, these results show that
the tone of spontaneous glutamatergic and GABAergic trans-
mission is reduced in the absence of SorCS1.
A decrease in mPSC frequency could be due to a reduced
probability of spontaneous release or a decrease in synapse
density. Given that our data indicates that the decrease in
mPSC frequency occurs only in SorCS1-deficient neurons and
not in neighboring non-electroporated cells, we focused on
postsynaptic mechanisms. We quantified excitatory and inhibi-
tory synapse density in DIV14 SorCS1flox/flox cortical neurons
electroporated with Cre or control plasmids. Loss of SorCS1
did not affect the density of puncta positive for the excitatory
synaptic markers PSD95 and VGluT1 (Figures 7G and 7H), nor
did it affect the density of dendritic protrusions (control 0.432 ±
0.045 versus Cre 0.445 ± 0.039 protrusions/mm; mean ± SEM;
n = 10 neurons per condition; not significant by Mann-Whitney
test). SorCS1 KO neurons displayed a significant decrease in
the density of puncta positive for the inhibitory synaptic markers
Gephyrin and VGAT (Figures 7I and 7J). These effects were spe-
cific to cortical neurons, given that loss of SorCS1 in hippocam-
pal neurons did not affect synapse density or mEPSC frequency
(Figures S7H–S7N). However, SorCS1 overexpression in hippo-
campal neurons increased functional excitatory synapse density
but did not affect inhibitory synapse density (Figures S7O–S7V).
These results show that loss of SorCS1 differentially affects
excitatory and inhibitory synapses: excitatory synapse density
is unaltered in SorCS1 KO neurons, whereas inhibitory synapse
density is decreased.
The decreased inhibitory synapse density in SorCS1 KO
neurons can account for the reduced mIPSC frequency in
these cells, but the decrease in mEPSC frequency must be
due to another mechanism. Given that AMPARs were consis-
tently identified as regulated by SorCS1 (Figure 6F), we asked
whether a loss of AMPAR surface expression at synapses might
explain the decreased mEPSC frequency in SorCS1 KO neu-
rons. Cortical DIV14 SorCS1flox/flox neurons electroporated with
Cre or GFP were fixed and immunostained under non-permea-
bilizing conditions for surface GluA1- and GluA2-containing
AMPARs. We found a significant decrease in overall GluA1 and
GluA2 surface levels (Figure 7K,L, N, O), as well as synaptic
GluA1 and GluA2 levels, in SorCS1 KO neurons compared to
control cells (Figure 7K, M, N, P). In contrast, dendritic and syn-
aptic surface levels of the b2/3 subunit of the inhibitory GABAA
receptor were not altered in SorCS1 KO neurons (Figure 7Q-S).
These results indicate that SorCS1 is required to maintain sur-
face and synaptic abundance of AMPARs.776 Neuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc.The decreasedmEPSC frequency in SorCS1 KO neurons sug-
gests that a population of synapses lacks AMPAR surface
expression in the absence of SorCS1. To test whether the frac-
tion of AMPAR-lacking synapses is increased inSorCS1KOneu-
rons, we labeled surface GluA1 and the NMDA-receptor-subunit
GluN1 under non-permeabilizing conditions, followed by a per-
meabilization step to label VGluT1 (Figure 7T). Quantification of
the density of synaptic surface GluN1 puncta lacking surface
GluA1 expression revealed a significant increase in the fraction
of AMPAR-lacking synapses in SorCS1 KO neurons (Figure 7U).
Together, these results show that loss of SorCS1 differentially
affects excitatory and inhibitory synapses: excitatory synapse
density is unaffected in SorCS1 KO neurons, but the fraction
of synapses lacking functional AMPARs is increased. The den-
sity of inhibitory synapses, on the other hand, is decreased in
SorCS1 KO neurons, but GABAAR surface expression at remain-
ing inhibitory synapses is not impaired.
DISCUSSION
Here, we identify the sorting receptor SorCS1 as a key regulator
of synaptic receptor trafficking. Our proteomic analyses identify
the synaptic adhesion molecule Nrxn and the AMPA glutamate
receptor as the major proteins sorted by SorCS1. SorCS1 local-
izes to early and recycling endosomes and regulates Nrxn and
AMPAR surface expression in neurons. SorCS1 is found in a mo-
lecular complex with Nrxn, other synaptic adhesion molecules,
and AMPARs. In cultured neurons, SorCS1 maintains surface
levels of these receptors. In vivo, SorCS1 maintains the synaptic
abundance of receptors regulating cell adhesion and synaptic
transmission, including Nrxns and AMPARs. Loss of SorCS1 de-
creases both glutamatergic and GABAergic synaptic transmis-
sion as a result of impaired AMPAR surface levels at excitatory
synapses and a decrease in inhibitory synapse density, respec-
tively. Together, our results show that SorCS1 regulates the traf-
ficking of neuronal receptors that are essential for synaptic
function.
Regulation of Synaptic Receptor Trafficking by SorCS1
Our findings show that the surface and synaptic levels of multiple
receptors are affected in the absence of SorCS1. How can the
loss of a sorting protein affect the expression of many surface re-
ceptors? Our MS analysis of affinity-purified SorCS1 complexes
identified AP-2-complex subunits. The AP-2 complex plays an
important role in the sorting of receptors from the cell surface
to endosomes (Traub, 2009), which regulate many processes
in neurons, including the cell surface distribution of receptors
(Yap and Winckler, 2012). In addition to the AP-2 complex,
SorCS1 also interacts with the retromer protein Vps35 (Lane
et al., 2010; Lane et al., 2013). The retromer complex is emerging
as a major regulator of endosomal sorting (Burd and Cullen,
2014) and regulates retrieval of transmembrane proteins from
endosomes to the TGN for recycling (Bonifacino and Hurley,
2008), as well as surface delivery of receptors from endosomes
(Small and Petsko, 2015). Knockdown of Vps35 in HeLa cells
downregulates the surface expression of 152 membrane pro-
teins (Steinberg et al., 2013). In these cells, the retromer main-
tains surface expression and prevents lysosomal degradation
of a broad array of receptors. The changes in surface proteome
composition after Vps35 knockdown in HeLa cells are reminis-
cent of the changes in receptor surface expression we observe
inSorCS1KOneurons. By interactingwith the AP-2 and retromer
complexes, SorCS1 links to major intracellular sorting pathways
regulating endocytosis and recycling of cargo, thereby acting as
a hub in the control of receptor surface expression in neurons. In
addition to direct effects of SorCS1 on receptor trafficking, some
of the changes in protein levels after SorCS1 loss of function are
most likely indirect. These might represent proteins that depend
on downregulated receptors for their stabilization or represent
compensatory changes.
Four independent proteomic approaches identified Nrxn and
AMPARs as the major proteins sorted by SorCS1, and two inde-
pendent quantitative proteomic analyses indicated that their sur-
face and synaptic levels were decreased in SorCS1 KO neurons.
Our data show that in the absence of SorCS1-mediated sorting,
Nrxn accumulates on the dendritic surface and is lost from the
axonal surface. A lack of suitable antibodies for the detection
of endogenous SorCS1 and Nrxn forced us to rely on overex-
pression of tagged constructs to address Nrxn trafficking, which
is a limitation of our study. The exact localization of Nrxns, and
whether Nrxns may also have a function in dendrites, remains
unclear. Loss of a-Nrxns affects NMDAR function and dendritic
morphology (Dudanova et al., 2007; Kattenstroth et al., 2004),
but conflicting results have been reported on the effects of
dendritic overexpression of Nrxn on synapse density (Taniguchi
et al., 2007; Zhang et al., 2010). Regardless of a postsynaptic
function of Nrxn, our results suggest that somatodendritic sort-
ing is required to maintain Nrxn levels on the axon surface. Inter-
estingly, the axonal targeting of the receptors L1/NgCAM and
the Nrxn family member CASPR2 depends on endocytosis in
the somatodendritic compartment. Upon interference with
endocytosis, these proteins are mis-sorted to the somatoden-
dritic surface and degraded in lysosomes (Bel et al., 2009; Yap
et al., 2008). Similarly, axonal trafficking of Nrxn may depend
on SorCS1-mediated endocytosis and endosomal sorting in
the somatodendritic domain, followed by transport of Nrxn into
axons. In conclusion, our data suggests that SorCS1 mediates
sorting of cargo proteins in endosomes to regulate their recycling
back to the cell surface and prevent cargo from entering lyso-
somal degradation pathways. More work is needed to delineate
the exact mechanisms by which SorCS1 regulates these intra-
cellular trafficking pathways.
SorCS1 and Synaptic Function
Loss of SorCS1 reduced spontaneous glutamatergic and
GABAergic synaptic transmission. The decrease in mPSC fre-
quency in SorCS1 KO neurons is cell-autonomous and did not
occur in neighboring non-transfected cells, indicating a post-
synaptic origin of these defects. We do not exclude the possi-
bility that there may be additional presynaptic defects in
SorCS1 KO neurons that we were unable to resolve in our
current experiments. Several proteins regulating presynaptic
function are downregulated in SorCS1 KO synaptosomes
(Table S5), but these do not seem to be involved in the pheno-
type we observe here. Instead, the decreased glutamatergic
transmission in SorCS1 KO neurons could be attributed toimpaired surface expression of AMPARs. Our data indicate
an increased fraction of excitatory synapses lacking functional
AMPARs in SorCS1 KO neurons, whereas the remaining syn-
apses appear to have normal AMPAR content. Similar impair-
ments in AMPAR surface levels have been observed after loss
of the intracellular trafficking regulators Vps35, the sorting
nexin SNX27, and Neurobeachin (Choy et al., 2014; Hussain
et al., 2014; Loo et al., 2014; Nair et al., 2013; Wang et al.,
2013). SorCS1, Vps35, and SNX27 are all linked to retromer
function, highlighting the importance of this complex in regu-
lating AMPAR trafficking.
Impaired trafficking of synaptic adhesion molecules could
also contribute to the decreased AMPAR synaptic levels in
SorCS1-deficient neurons. The interaction of Nrxn with Nlgn1
and LRRTM2 controls AMPAR trafficking (Aoto et al., 2013).
Nlgn3, which was strongly downregulated on the surface of
SorCS1 KO neurons, also affects AMPAR trafficking (Chanda
et al., 2015). Thus, mis-sorting of adhesion molecules in SorCS1
KO neurons could affect AMPAR trafficking. The decreased
inhibitory synaptic transmission in SorCS1 KO neurons, on the
other hand, did not result from impaired GABAAR trafficking
but could be attributed to a decrease in inhibitory synapse
density. Decreased abundance of Nlgn2 (Table S5) and Nlgn3
(Figure 5), which localize to inhibitory synapses (Budreck and
Scheiffele, 2007; Poulopoulos et al., 2009), could lead to reduc-
tions in inhibitory synapse density. Alternatively, this decrease
might reflect a compensatory response to the reduced glutama-
tergic transmission in SorCS1 KO neurons, given that overex-
pression of SorCS1 in hippocampal neurons did not affect inhib-
itory synapse density.
SorCS1 and Synaptopathies
SORCS genes have been associated with a range of synaptopa-
thies, including Alzheimer disease and autism (Christoforou
et al., 2011; Grupe et al., 2006; Lionel et al., 2011; Ollila et al.,
2009; Reitz et al., 2011; Sanders et al., 2012). Impaired receptor
trafficking resulting from SORCS1mutations could contribute to
synaptic-composition and -function defects underlying synap-
topathies. A SorCS1 cargo protein directly relevant to disease
is APP, which accumulates in endosomes in the absence of
SorCS1, increasing levels of Alzheimer Ab peptide (Lane et al.,
2010; Lane et al., 2013; Reitz et al., 2011), which is detrimental
to synapses (Mucke and Selkoe, 2012). Loss of SorCS1 also af-
fects trafficking of the adhesion proteins Nlgns and Nrxns,
which regulate many aspects of synapse development and
function (Krueger et al., 2012) and have been linked to autism
and schizophrenia (Su¨dhof, 2008). Interestingly, SorCS2 acts
as a coreceptor of the p75 neurotrophin receptor in mediating
proneurotrophin-induced growth cone collapse (Anastasia
et al., 2013; Deinhardt et al., 2011; Glerup et al., 2014), suggest-
ing that other SorCS proteins could affect neuronal wiring in
different ways.
Our functional analysis indicates that the impact of loss of
SorCS1 on excitatory synapses is relatively subtle, increasing
the fraction of functional AMPAR-lacking synapses, thereby
dampeningsynaptic transmissionbut not abolishing it. Thepersis-
tence of immature, AMPAR-lacking synapses could affect the
plasticity and activity-dependent postnatal refinement of corticalNeuron 87, 764–780, August 19, 2015 ª2015 Elsevier Inc. 777
circuits, and has been observed in a model of fragile X syndrome
(Harlow et al., 2010). Reduced synaptic activity might eventually
lead to synapse loss and neuronal degeneration. Impaired intra-
cellular trafficking is emerging as a common theme in neuro-
degenerative diseases (Small and Petsko, 2015), underscoring
the importance of regulation of receptor trafficking for themainte-
nance of synaptic composition and function.
EXPERIMENTAL PROCEDURES
Additional details are provided in online Supplemental Experimental
Procedures.
Neuronal Cultures and Transfections
Neurons were cultured from E18 or P0/1 Long-Evans rats (Charles River) or
P1 C57BL/6J SorCS1flox/flox mice and plated on poly-D-lysine (Millipore)
and laminin (Invitrogen) coated glass coverslips (Glaswarenfabrik Karl Hecht),
chamber slides, and dishes (Nalge Nunc International). Neurons were main-
tained in Neurobasal-A medium or Neurobasal medium (Invitrogen) supple-
mented with B27, glucose, glutamax, penicillin/streptomycin (Invitrogen),
20 mg/ml insulin (Sigma), and 25 mM b-mercaptoethanol. Neurons were elec-
troporated with plasmid DNA just before plating with an AMAXA Nucleofector
kit (Lonza). Transfections were performed at 7 days in vitro with Effectene
(QIAGEN).
Animal Experiments
All animal experiments were conducted according to the University of Califor-
nia, San Diego (UCSD), The Scripps Research Institute (TSRI), and Katholieke
Universiteit (KU) Leuven ethical guidelines and approved by the UCSD institu-
tional animal care and use committee (IACUC; approved protocol nos. S03154
and S03155), TSRI IACUC and Department of Animal Resources (approved
protocol no. 07-0083), and the KU Leuven ethical committee (approved proto-
col nos. P015-2013 and P026-2013). For euthanasia, newborn pups were
immediately decapitated, and adult animals were injected with a lethal dose
of sodium pentobarbital.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and five tables and can be found with this article online at
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